Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Gut Microbiome Connections and Microbiome-Based Interventions in Inflammatory Skin Diseases

Description

The talk emphasized that inflammatory skin diseases cannot be fully managed without considering the gut microbiome, which includes bacteria, viruses, and fungi and helps regulate immunity, barrier integrity, and inflammation. Gut dysbiosis was linked to systemic immune activation, with disease-specific patterns seen in atopic dermatitis, psoriasis, acne, rosacea, lupus, hidradenitis suppurativa, and vitiligo. Examples included reduced Lactobacillus and Bifidobacterium in atopic dermatitis, correlations between microbiome shifts and TH17/TH2 pathways in psoriasis and eczema, Ruminococcus navus as a potential trigger in lupus flares, and gut-derived metabolites and neuromodulators affecting itch and skin inflammation. The speaker highlighted that lifestyle factors such as unhealthy diet, stress, alcohol, antibiotics, travel, sleep, and exercise influence the gut barrier, while diet and microbial interventions can help. Evidence discussed supported strain-specific probiotics, prebiotics, synbiotics, and postbiotics; omega-3 fatty acids and improving the omega-6:omega-3 balance; Mediterranean-style eating; reducing dairy and high-sugar/high-fat foods; increasing fiber and vegetables; and, in some conditions, targeted approaches such as anti-yeast diets for hidradenitis, treatment of H. pylori or SIBO in rosacea, and fecal microbiome transplant as an emerging therapy. Overall, the message was that practical, microbiome-focused interventions may improve skin disease outcomes and should be tailored to the specific condition and patient.

View more

Conclusions

  • Inflammatory skin diseases appear to be linked to gut dysbiosis and intestinal barrier dysfunction, supporting a bidirectional gut-skin axis.
  • Different dermatoses show distinct but overlapping gut microbiome signatures, suggesting microbiome patterns may help explain disease-specific inflammation.
  • Gut microbial changes can amplify systemic immune dysregulation by increasing pro-inflammatory signaling and reducing anti-inflammatory pathways.
  • Lifestyle factors such as diet, stress, alcohol, travel, and antibiotics can substantially disrupt gut microbiota, whereas sleep, exercise, and dietary changes are modifiable targets.
  • Probiotics can be beneficial, but their effects are strain-specific and cannot be generalized across products or conditions.
  • Maternal and infant probiotic strategies, along with breastfeeding, may reduce atopic dermatitis risk in high-risk infants.
  • Lactobacillus and Bifidobacterium-based probiotics are associated with improved psoriasis outcomes and reduced inflammatory markers.
  • In rosacea, probiotics may enhance antibiotic treatment and reduce sebum, clinical severity, and antibiotic resistance burden.
  • Omega-3 fatty acids appear to be anti-inflammatory and may improve acne, reduce allergic disease risk, and support beneficial gut microbes.
  • A lower omega-6 to omega-3 balance seems more favorable than high omega-6 dominance for inflammatory and allergic skin disease.
  • Mediterranean-style diets are broadly beneficial, improving microbial diversity, increasing short-chain fatty acids, and reducing psoriasis severity.
  • Dairy and high-sugar or high-fat dietary patterns may worsen acne, while reducing dairy and using lower-glycemic meal timing may help.
  • Dietary yeast reduction, weight loss, and Mediterranean-style eating may improve hidradenitis suppurativa in selected patients.
  • Helicobacter pylori and SIBO may contribute to rosacea in some patients, but the association is inconsistent and strongest in selected subgroups.
  • Overall, the presentation concludes that dermatologic care should increasingly incorporate gut-focused, diet-based, and microbiome-modulating strategies alongside conventional treatment.
  • Okada et al., 2020
  • Azzouz et al., 2023
  • Kim et al., 2019
  • Zhao et al. 2022
  • Qi et al. 2023
  • Huang R. et al. PMID 28932705
  • Gdalevich et al. 2001
  • Lyons et al. 2020
  • Memariani and Memariani, Heliyon, 2025
  • Yu J et al. Effect of combined probiotics and doxycycline therapy on the gut-skin axis in rosacea. mSystems. 2024 Nov 19;9(11):e0120124. PMID: 39475254.#10.1128/msystems.01201-24
  • Adebamowo et al., 2008
  • Melnik, 2011
  • Li Y, Li Q, Cao Z, Wu J. The causal association of polyunsaturated fatty acids with allergic disease: A two-sample Mendelian randomization study. Front Nutr. 2022 Sep 9;9:962787. PMID: 36159460.#10.3389/fnut.2022.962787
  • Liu et al. 2019
  • Harwood 2023
  • Fiorindi et al. 2021
  • Garbicz et al. 2021
  • Phan et al. 2018
  • Zanesco et al. 2022
  • Meink et al., 2011
  • Ulvestad et al., 2017
  • Jorgensen et al., 2017
  • Holmes, 2013
  • Wedi & Kapp, 2002